Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$286.57M+6.0%$270.28M+6.1%$254.79M+5.8%$240.88M+3.5%$232.79M+3.8%
$121.56M+5.9%$114.82M+7.0%$107.3M+6.9%$100.37M+4.4%$96.11M+5.6%
$165.01M+6.1%$155.46M+5.4%$147.49M+5.0%$140.52M+2.8%$136.68M+2.6%
57.6%+0.1pp57.5%-0.4pp57.9%-0.4pp58.3%-0.4pp58.7%-0.7pp
$2.8M-7.2%$3.02M-6.4%$3.22M+0.6%$3.2M+2.9%$3.12M+1.5%
$127.73M+5.2%$121.37M+3.4%$117.36M+4.7%$112.11M+2.1%$109.81M+3.4%
$23.4M+2.0%$22.95M+9.1%$21.03M+0.1%$21.02M+7.6%$19.54M+9.1%
8.2%-0.3pp8.5%+0.2pp8.3%-0.5pp8.7%+0.3pp8.4%+0.4pp
-$698K+15.3%-$824K-35.7%-$607K-86.8%-$325K+27.3%-$447K+42.4%
$212K-15.9%$252K
$22.1M+1.5%$21.77M+8.5%$20.07M-1.8%$20.43M+15.3%$17.71M+9.5%
$6.72M+5.1%$6.39M+5.1%$6.08M-1.0%$6.14M+18.2%$5.2M+9.1%
$14.89M-0.3%$14.93M+9.7%$13.61M-2.6%$13.98M+13.7%$12.29M+9.1%
5.2%-0.3pp5.5%+0.2pp5.3%-0.5pp5.8%+0.5pp5.3%+0.3pp
$0.370.0%$0.37+8.8%$0.34-2.9%$0.35+12.9%$0.31+6.9%
$53.03M+2.8%$51.56M+6.4%$48.44M+2.4%$47.29M+4.6%$45.23M+4.5%
18.5%-0.6pp19.1%+0.1pp19%-0.6pp19.6%+0.2pp19.4%+0.1pp
$23.4M+2.0%$22.95M+9.1%$21.03M+0.1%$21.02M+7.6%$19.54M+9.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Viemed Healthcare, Inc.'s revenue?
Viemed Healthcare, Inc. (VMD) generated $286.6M in revenue over the trailing twelve months, up 23.1% year over year.
Is Viemed Healthcare, Inc. profitable?
Viemed Healthcare, Inc. reported $14.9M in net income over the trailing twelve months, a 5.2% net margin.
What are Viemed Healthcare, Inc.'s profit margins?
Gross margin is 57.6% and operating margin is 8.2%, with a 5.2% net margin.
What is Viemed Healthcare, Inc.'s earnings per share?
Viemed Healthcare, Inc.'s diluted EPS over the trailing twelve months is $0.37.
Where does Viemed Healthcare, Inc.'s income statement data come from?
Every line is extracted from Viemed Healthcare, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.